Biotech Stock News (ONCE) (AAVL) (CLDN) (ADXS) (OPK) (PFE)

Spark Therapeutics (NASDAQ:ONCE) On October 5, 2015 shares of Spark Therapeutics ended the day up at least 25% after the company announced that it had achieved positive phase 3 results in patients with a rare form of blindness. This rare form of blindness stems from a mutation in the RPE65 gene of the eye which … Read more

Biotech Stock News (LXRX) (BIOC) (LLY) (AMGN) (AQXP)

Lexicon Pharmaceuticals (NASDAQ:LXRX)  On August 3, 2015 shares of Lexicon Pharmaceuticals were up 61% after the company posted positive phase 3 Results in Patients with Carcinoid Syndrome. Carcinoid Syndrome occurs when a carcinoid tumor advances to a later stage. Typically this disease targets the lining of the lungs or stomach of the patient and has … Read more

Biotech Stock News (OREX) (TKPHF) (VRTX) (PBYI)

Orexigen Therapeutics (NASDAQ:OREX)  On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outcome study had to be terminated early. The “LIGHT” study recruited up to 9,000 patients to determine if patients taking Contrave have an increased risk of cardiovascular issues. The mess up occurred because the early … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more